DONOR: Factors which place the donor at increased risk for complications from leukapheresis or granulocyte-colony stimulating factor (G-CSF) therapy could be harvested for bone marrow (BM) if safer for the donor and if approved by PI
DONOR: Factors which place the donor at increased risk for complications from leukapheresis or G-CSF therapy
DONOR: Cardiac risk factors precluding ability to undergo leukapheresis
DONOR: Factors which place the donor at increased risk for complications from leukapheresis or granulocyte-colony stimulating factor (G-CSF) therapy
DONOR: Factors which place the donor at increased risk for complications from leukapheresis
DONOR: Cardiac risk factors precluding ability to undergo leukopheresis
HAPLO-IDENTICAL DONOR: Factors which place the donor at increased risk for complications from leukapheresis or granulocyte colony-stimulating factor (G-CSF) therapy (e.g., active autoimmune disease, sickle cell trait, symptomatic coronary artery disease requiring therapy)
DONOR: Factors which place the donor at increased risk for complications from leukapheresis or G-CSF (filgrastim) therapy (e.g. autoimmune disease, sickle cell trait, symptomatic coronary artery disease requiring therapy)
Donor has cardiac risk factors precluding ability to undergo leukapheresis
